Aegate medicine verification now live in Cyprus

Aegate has added Cyprus to the list of EU countries that have implemented its medicines verification system, which protects consumers from counterfeits, expired or recalled drugs at the point of dispensing.

Cyprus joins several other EU countries with Aegate's verification system in place. Belgium, Greece and Italy have been using the platform since 2007, and the company has also started scanning serialised medicinal products in Germany, the Netherlands and the UK. The full text of the press release follows:

---

Cyprus - patient safety from counterfeit medicines thanks to Aegate

Aegate, the leader in medicine verification and authentication services, is pleased to announce an important milestone has been reached in Cyprus with live scanning of medicines at point of dispense – enabling the ability to ensure patient safety against counterfeit and expired medicines.

Pharmacies throughout Cyprus now have the ability to be Aegate Safe, putting patient safety first and expanding the opportunity to provide a deeper level of patient care.

The Aegate model has been successfully tested by over 20,000 pharmacy dispensing points in the last 8 years in several European countries. The positive overall impact for both the pharmacy and the service provider has been increased patient safety by stopping 1.8 Million medicines which should not have been dispensed.

The introduction of the Falsified Medicines Directive requires medicines to be uniquely serialised, protected by tamper-proof seals and their authenticity verified before being dispensed to patients. Every pharmacy in the EU will be obligated to have the ability to scan the serialised codes - Cyprus is Aegate Ready.

Mark De Simone, Aegate CEO commented: "We are very proud to have another European Country go live with the Aegate service, ready to protect patients from falsified, expired or recalled
medicines: Patient Safety cannot wait!"